• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过控制抗M1因子减少肺纤维化中的M2巨噬细胞。

Reducing M2 macrophage in lung fibrosis by controlling anti-M1 agent.

作者信息

Bahram Yazdroudi Fatemeh, Malek Alaeddin

机构信息

Department of Applied Mathematics, Faculty of Mathematical Sciences, Tarbiat Modares University, Tehran, Iran.

出版信息

Sci Rep. 2025 Feb 3;15(1):4120. doi: 10.1038/s41598-024-76561-0.

DOI:10.1038/s41598-024-76561-0
PMID:39900943
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11791193/
Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease characterized by excessive scarring and fibrosis due to the abnormal accumulation of extracellular matrix components, primarily collagen. This study aims to design and solve an optimal control problem to regulate M2 macrophage activity in IPF, thereby preventing fibrosis formation by controlling the anti-M1 agent. The research models the diffusion of M2 macrophages in inflamed tissue using a novel dynamical system with partial differential equation (PDE) constraints. The control problem is formulated to minimize fibrosis by regulating an anti-M1 agent. The study employs a two-step process of discretization followed by optimization, utilizing the Galerkin spectral method to transform the M2 diffusion PDE into an algebraic system of ordinary differential equations (ODEs). The optimal control problem is then solved using Pontryagin/s minimum principle, canonical Hamiltonian equations, and extended Riccati differential equations. The numerical simulations indicate that without control, M2 macrophage levels increase and stabilize, contributing to fibrosis. In contrast, the optimal control strategy effectively reduces M2 macrophages, preventing fibrosis formation within 120 days. The results highlight the potential of the proposed optimal control approach in modulating tissue repair processes and mitigating the progression of IPF. This study underscores the significance of targeting M2 macrophages and employing mathematical methods to develop innovative therapies for lung fibrosis.

摘要

特发性肺纤维化(IPF)是一种慢性肺部疾病,其特征是由于细胞外基质成分(主要是胶原蛋白)异常积累导致过度瘢痕形成和纤维化。本研究旨在设计并解决一个最优控制问题,以调节IPF中的M2巨噬细胞活性,从而通过控制抗M1因子来预防纤维化形成。该研究使用具有偏微分方程(PDE)约束的新型动力学系统对M2巨噬细胞在炎症组织中的扩散进行建模。控制问题的制定是通过调节抗M1因子来使纤维化最小化。该研究采用了两步过程,即离散化然后优化,利用伽辽金谱方法将M2扩散PDE转化为常微分方程(ODE)的代数系统。然后使用庞特里亚金最小原理、正则哈密顿方程和扩展的里卡蒂微分方程来解决最优控制问题。数值模拟表明,在没有控制的情况下,M2巨噬细胞水平会升高并稳定下来,导致纤维化。相比之下,最优控制策略有效地减少了M2巨噬细胞,在120天内预防了纤维化形成。结果突出了所提出的最优控制方法在调节组织修复过程和减轻IPF进展方面的潜力。本研究强调了靶向M2巨噬细胞以及采用数学方法开发肺纤维化创新疗法的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74f2/11791193/1c52db59377f/41598_2024_76561_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74f2/11791193/a969fb5e3117/41598_2024_76561_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74f2/11791193/9b0b4f57b520/41598_2024_76561_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74f2/11791193/e33ea10dd3ee/41598_2024_76561_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74f2/11791193/57c1e411c0fa/41598_2024_76561_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74f2/11791193/c8d3478da7de/41598_2024_76561_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74f2/11791193/34a9bcc35458/41598_2024_76561_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74f2/11791193/6bb60c8f01a4/41598_2024_76561_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74f2/11791193/2503a75278d2/41598_2024_76561_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74f2/11791193/60c6931632be/41598_2024_76561_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74f2/11791193/1e0068b54707/41598_2024_76561_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74f2/11791193/d1d425a13e27/41598_2024_76561_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74f2/11791193/1c52db59377f/41598_2024_76561_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74f2/11791193/a969fb5e3117/41598_2024_76561_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74f2/11791193/9b0b4f57b520/41598_2024_76561_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74f2/11791193/e33ea10dd3ee/41598_2024_76561_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74f2/11791193/57c1e411c0fa/41598_2024_76561_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74f2/11791193/c8d3478da7de/41598_2024_76561_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74f2/11791193/34a9bcc35458/41598_2024_76561_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74f2/11791193/6bb60c8f01a4/41598_2024_76561_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74f2/11791193/2503a75278d2/41598_2024_76561_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74f2/11791193/60c6931632be/41598_2024_76561_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74f2/11791193/1e0068b54707/41598_2024_76561_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74f2/11791193/d1d425a13e27/41598_2024_76561_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74f2/11791193/1c52db59377f/41598_2024_76561_Fig12_HTML.jpg

相似文献

1
Reducing M2 macrophage in lung fibrosis by controlling anti-M1 agent.通过控制抗M1因子减少肺纤维化中的M2巨噬细胞。
Sci Rep. 2025 Feb 3;15(1):4120. doi: 10.1038/s41598-024-76561-0.
2
Macrophage polarization and its impact on idiopathic pulmonary fibrosis.巨噬细胞极化及其对特发性肺纤维化的影响。
Front Immunol. 2024 Jul 26;15:1444964. doi: 10.3389/fimmu.2024.1444964. eCollection 2024.
3
Macrophages: friend or foe in idiopathic pulmonary fibrosis?巨噬细胞:特发性肺纤维化的朋友还是敌人?
Respir Res. 2018 Sep 6;19(1):170. doi: 10.1186/s12931-018-0864-2.
4
Optimal controlling of anti-TGF-[Formula: see text] and anti-PDGF medicines for preventing pulmonary fibrosis.抗 TGF-β和抗 PDGF 药物防治肺纤维化的最优控制。
Sci Rep. 2023 Sep 12;13(1):15073. doi: 10.1038/s41598-023-41294-z.
5
Nanoengineered immunosuppressive therapeutics modulating M1/M2 macrophages into the balanced status for enhanced idiopathic pulmonary fibrosis therapy.纳米工程免疫抑制治疗通过调节 M1/M2 巨噬细胞向平衡状态,增强特发性肺纤维化治疗。
Nanoscale. 2020 Apr 30;12(16):8664-8678. doi: 10.1039/d0nr00750a.
6
Complement factor H drives idiopathic pulmonary fibrosis by autocrine C3 regulation, suppressing macrophage phagocytosis and enhancing fibrotic progression.补体因子H通过自分泌C3调节驱动特发性肺纤维化,抑制巨噬细胞吞噬作用并促进纤维化进展。
Biochem Biophys Res Commun. 2025 Jan;745:151220. doi: 10.1016/j.bbrc.2024.151220. Epub 2024 Dec 19.
7
Tacrolimus ameliorates bleomycin-induced pulmonary fibrosis by inhibiting M2 macrophage polarization via JAK2/STAT3 signaling.他克莫司通过抑制 JAK2/STAT3 信号通路抑制 M2 型巨噬细胞极化来改善博来霉素诱导的肺纤维化。
Int Immunopharmacol. 2022 Dec;113(Pt A):109424. doi: 10.1016/j.intimp.2022.109424. Epub 2022 Nov 8.
8
IL20Rb aggravates pulmonary fibrosis through enhancing bone marrow derived profibrotic macrophage activation.IL20Rb 通过增强骨髓来源的致肺纤维化巨噬细胞激活加重肺纤维化。
Pharmacol Res. 2024 May;203:107178. doi: 10.1016/j.phrs.2024.107178. Epub 2024 Apr 5.
9
Cepharanthine attenuates pulmonary fibrosis via modulating macrophage M2 polarization.胡椒乙胺通过调节巨噬细胞 M2 极化减轻肺纤维化。
BMC Pulm Med. 2024 Sep 11;24(1):444. doi: 10.1186/s12890-024-03250-z.
10
A novel ex vivo approach for investigating profibrotic macrophage polarization using murine precision-cut lung slices.一种使用小鼠精密切割肺切片研究促纤维化巨噬细胞极化的新型体外方法。
Biochem Biophys Res Commun. 2024 Dec 31;741:151038. doi: 10.1016/j.bbrc.2024.151038. Epub 2024 Nov 20.

本文引用的文献

1
Macrophage polarization and its impact on idiopathic pulmonary fibrosis.巨噬细胞极化及其对特发性肺纤维化的影响。
Front Immunol. 2024 Jul 26;15:1444964. doi: 10.3389/fimmu.2024.1444964. eCollection 2024.
2
iDNA-OpenPrompt: OpenPrompt learning model for identifying DNA methylation.iDNA-OpenPrompt:用于识别DNA甲基化的OpenPrompt学习模型。
Front Genet. 2024 Apr 16;15:1377285. doi: 10.3389/fgene.2024.1377285. eCollection 2024.
3
Exosomes: efficient macrophage-related immunomodulators in chronic lung diseases.外泌体:慢性肺部疾病中高效的巨噬细胞相关免疫调节剂
Front Cell Dev Biol. 2024 Apr 9;12:1271684. doi: 10.3389/fcell.2024.1271684. eCollection 2024.
4
NIMEQ-SACNet: A novel self-attention precision medicine model for vision-threatening diabetic retinopathy using image data.NIMEQ-SACNet:一种基于图像数据的新型自注意力精准医学模型,用于威胁视力的糖尿病性视网膜病变。
Comput Biol Med. 2024 Mar;171:108099. doi: 10.1016/j.compbiomed.2024.108099. Epub 2024 Feb 11.
5
YOLO and residual network for colorectal cancer cell detection and counting.用于结直肠癌细胞检测与计数的YOLO和残差网络。
Heliyon. 2024 Jan 11;10(2):e24403. doi: 10.1016/j.heliyon.2024.e24403. eCollection 2024 Jan 30.
6
Dynamics of the optimality control of transmission of infectious disease: a sensitivity analysis.传染病传播最优控制的动力学:敏感性分析。
Sci Rep. 2024 Jan 10;14(1):1041. doi: 10.1038/s41598-024-51540-7.
7
Advancing single-cell RNA-seq data analysis through the fusion of multi-layer perceptron and graph neural network.通过多层感知机和图神经网络的融合来推进单细胞 RNA-seq 数据分析。
Brief Bioinform. 2023 Nov 22;25(1). doi: 10.1093/bib/bbad481.
8
Improved Support Vector Machine based on CNN-SVD for vision-threatening diabetic retinopathy detection and classification.基于 CNN-SVD 的改进支持向量机在威胁视力的糖尿病视网膜病变检测和分类中的应用。
PLoS One. 2024 Jan 2;19(1):e0295951. doi: 10.1371/journal.pone.0295951. eCollection 2024.
9
Optimal controlling of anti-TGF-[Formula: see text] and anti-PDGF medicines for preventing pulmonary fibrosis.抗 TGF-β和抗 PDGF 药物防治肺纤维化的最优控制。
Sci Rep. 2023 Sep 12;13(1):15073. doi: 10.1038/s41598-023-41294-z.
10
Modeling the competitive transmission of the Omicron strain and Delta strain of COVID-19.新冠病毒奥密克戎毒株与德尔塔毒株的竞争性传播建模
J Math Anal Appl. 2023 Oct 15;526(2):127283. doi: 10.1016/j.jmaa.2023.127283. Epub 2023 Mar 31.